Related Experiment Videos

Interleukin-6 and acute coronary syndrome

U Ikeda1, T Ito, K Shimada

  • 1Department of Cardiology, Jichi Medical School, Tochigi, Japan. uikeda@jichi.ac.jp

Clinical Cardiology
|November 21, 2001
PubMed

Insights

Interleukin-6 (IL-6) levels indicate plaque inflammation and rupture risk in atherosclerosis. Monitoring IL-6 may guide anti-inflammatory treatments to prevent acute myocardial infarction (AMI) and restenosis after PCI.

Area of Science:

  • Cardiology
  • Inflammation Biology

Background:

  • Atherosclerosis is increasingly recognized as a chronic inflammatory disease.
  • Interleukin-6 (IL-6) and C-reactive protein (CRP) are key inflammatory markers.
  • Elevated IL-6 is linked to acute myocardial infarction (AMI) and unstable angina.

Purpose of the Study:

  • To investigate the role of IL-6 in atherosclerosis plaque vulnerability and restenosis.
  • To explore the potential of IL-6 as a biomarker for cardiovascular risk.
  • To assess the implications of IL-6 levels for anti-inflammatory therapeutic strategies.

Main Methods:

  • Measurement of plasma and coronary sinus IL-6 concentrations.
  • Correlation analysis of IL-6 levels with clinical events like AMI and unstable angina.
  • Evaluation of IL-6 changes post-percutaneous coronary intervention (PCI) and association with restenosis.

Main Results:

  • Circulating IL-6 levels are elevated in patients with AMI and unstable angina, but not stable angina.
  • Increased coronary sinus IL-6 concentrations are observed after PCI.
  • Higher IL-6 levels post-PCI correlate with the development of late restenosis.

Conclusions:

  • Plasma IL-6 concentration reflects the intensity of atherosclerotic plaque inflammation and vulnerability.
  • IL-6 plays a role in both plaque instability and restenosis formation after PCI.
  • Screening for IL-6 and utilizing anti-inflammatory treatments may reduce the risk of future AMI.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...